Clinical Trial Update: A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Mircera (methoxy polyethylene glycol-epoetin beta) for anemia in Filipino patients with chronic kidney disease; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED